Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
22.73
0.85 (3.88%)
BSENSE

Oct 09

BSE+NSE Vol: 3.26 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Smruthi Organic
Coral Labs.
Medico Remedies
Syschem (India)
Natural Capsules
Brooks Lab.
Oxygenta Pharma
Nectar Lifesci.
Kerala Ayurveda
Speciality Medi.
Bio Medica Lab
Why is Medico Remedies Ltd ?
1
High Management Efficiency with a high ROCE of 15.04%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.89 times
3
Poor long term growth as Net Sales has grown by an annual rate of 14.28% over the last 5 years
4
The company has declared Positive results for the last 5 consecutive quarters
  • NET SALES(Q) At Rs 56.81 cr has Grown at 37.55%
  • PBDIT(Q) Highest at Rs 7.15 cr.
  • PBT LESS OI(Q) Highest at Rs 5.45 cr.
5
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
6
With ROCE of 15.8, it has a Fair valuation with a 5.3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -9.38%, its profits have risen by 30% ; the PEG ratio of the company is 1
7
Majority shareholders : Promoters
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medico Remedies for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Medico Remedies
-55.79%
-0.16
58.05%
Sensex
-11.8%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.39%
EBIT Growth (5y)
36.46%
EBIT to Interest (avg)
8.16
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
2.30
Tax Ratio
27.16%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
15.69%
ROE (avg)
15.76%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
36
Price to Book Value
2.50
EV to EBIT
14.09
EV to EBITDA
11.64
EV to Capital Employed
2.25
EV to Sales
0.86
PEG Ratio
0.40
Dividend Yield
NA
ROCE (Latest)
13.58%
ROE (Latest)
18.31%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
PAT(Latest six months)

At Rs 8.38 cr has Grown at 36.04%

NET SALES(Q)

Highest at Rs 69.40 cr

-1What is not working for the Company
NON-OPERATING INCOME(Q)

is 35.03 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is working for Medico Remedies
Net Sales - Quarterly
At Rs 69.40 cr has Grown at 81.44%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Latest six months
At Rs 8.38 cr has Grown at 36.04%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 69.40 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Medico Remedies
Non Operating Income - Quarterly
is 35.03 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT